These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 34603482

  • 1. The Role of Change Rates of CYFRA21-1 and CEA in Predicting Chemotherapy Efficacy for Non-Small-Cell Lung Cancer.
    Zhao T, Mao G, Chen M.
    Comput Math Methods Med; 2021; 2021():1951364. PubMed ID: 34603482
    [Abstract] [Full Text] [Related]

  • 2. CYFRA 21-1 is an early predictor of chemotherapeutic effectiveness in advanced nonsmall cell lung cancer: An observational study.
    Zhao T, Jin Y, Mao G, Wei Y, Wu G, Ye X, Zhou Y, Yuan G, Gao L, Hong Y, Chen Y, Hong C, Zhou H, Su D, Qin Z, Lu L.
    Medicine (Baltimore); 2016 Dec; 95(52):e5748. PubMed ID: 28033287
    [Abstract] [Full Text] [Related]

  • 3. The Diagnostic and Prognostic Value of the Combination of Tumor M2-Pyruvate Kinase, Carcinoembryonic Antigen, and Cytokeratin 19 Fragment in Non-Small Cell Lung Cancer.
    Li L, Xu Y, Wang Y, Zhang Q, Wang Y, Xu C.
    Technol Cancer Res Treat; 2024 Dec; 23():15330338241265983. PubMed ID: 39043046
    [Abstract] [Full Text] [Related]

  • 4. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients.
    Dal Bello MG, Filiberti RA, Alama A, Orengo AM, Mussap M, Coco S, Vanni I, Boccardo S, Rijavec E, Genova C, Biello F, Barletta G, Rossi G, Tagliamento M, Maggioni C, Grossi F.
    J Transl Med; 2019 Mar 08; 17(1):74. PubMed ID: 30849967
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Variations in Serum CEA and CYFRA21-1 Levels Before and After Surgery Facilitate Prognosis of Non-small Cell Lung Cancer Patients].
    Duan X, Cui Y, Gong M, Tian F, Shi G, Wu B, Liu M, Guo J, Kong Y.
    Zhongguo Fei Ai Za Zhi; 2015 Jun 08; 18(6):358-64. PubMed ID: 26104892
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
    Ma L, Xie XW, Wang HY, Ma LY, Wen ZG.
    Asian Pac J Cancer Prev; 2015 Jun 08; 16(12):4891-4. PubMed ID: 26163610
    [Abstract] [Full Text] [Related]

  • 12. Clinical evaluation and therapeutic monitoring value of serum tumor markers in lung cancer.
    Wang L, Wang D, Zheng G, Yang Y, Du L, Dong Z, Zhang X, Wang C.
    Int J Biol Markers; 2016 Feb 28; 31(1):e80-7. PubMed ID: 26560853
    [Abstract] [Full Text] [Related]

  • 13. Prediction of Pleural Invasion in Challenging Non-Small-Cell Lung Cancer Patients Using Serum and Imaging Markers.
    Zhu K, Chen L, He C, Lang Y, Kong X, Qu C, Xu S.
    Dis Markers; 2020 Feb 28; 2020():6430459. PubMed ID: 32089756
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic value of serum CYFRA21-1 and CEA for non-small-cell lung cancer.
    Zhang ZH, Han YW, Liang H, Wang LM.
    Cancer Med; 2015 Nov 28; 4(11):1633-8. PubMed ID: 26333429
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The diagnostic significance of single or combination lung cancer-related serum biomarkers in high risk lung cancer patients].
    Ni J, Guo Z, Zhang L.
    Zhonghua Nei Ke Za Zhi; 2016 Jan 28; 55(1):25-30. PubMed ID: 26796649
    [Abstract] [Full Text] [Related]

  • 18. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
    Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Uenishi T, Wakasa K, Suehiro S.
    Lung Cancer; 2007 Dec 28; 58(3):369-75. PubMed ID: 17697728
    [Abstract] [Full Text] [Related]

  • 19. Predictive Role of CYFRA21-1 and CEA for Subsequent Docetaxel in Non-small Cell Lung Cancer Patients.
    Sone K, Oguri T, Ito K, Kitamura Y, Inoue Y, Takeuchi A, Fukuda S, Takakuwa O, Maeno K, Asano T, Kanemitsu Y, Ohkubo H, Takemura M, Ito Y, Niimi A.
    Anticancer Res; 2017 Sep 28; 37(9):5125-5131. PubMed ID: 28870944
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of CYFRA21-1, CEA and hemoglobin in patients with esophageal squamous cancer undergoing concurrent chemoradiotherapy.
    Zhang HQ, Wang RB, Yan HJ, Zhao W, Zhu KL, Jiang SM, Hu XG, Yu JM.
    Asian Pac J Cancer Prev; 2012 Sep 28; 13(1):199-203. PubMed ID: 22502668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.